| Bioactivity | Propyl-GSK2793660 is a potent cathepsin C inhibitor that holds potential for treating cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis, and bronchiectasis. |
| CAS | 1613458-71-1 |
| Formula | C22H31N3O3 |
| Molar Mass | 385.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986) |
Propyl-GSK2793660
CAS: 1613458-71-1 F: C22H31N3O3 W: 385.50
Propyl-GSK2793660 is a potent cathepsin C inhibitor that holds potential for treating cystic fibrosis, noncystic fibrosi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.